Relmada Therapeutics Inc. (RLMD)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 11 Sep 2024 |
TRAVERSA SERGIO |
Chief Executive Officer |
11 Sep 2024 |
51,407 |
2.99 |
153,707 |
| 11 Sep 2024 |
TRAVERSA SERGIO |
Chief Executive Officer |
10 Sep 2024 |
33,014 |
2.75 |
90,788 |
| 11 Sep 2024 |
TRAVERSA SERGIO |
Chief Executive Officer |
09 Sep 2024 |
55,579 |
2.71 |
150,619 |
| 11 Sep 2024 |
CASAMENTO CHARLES J |
Director |
09 Sep 2024 |
13,000 |
2.56 |
33,280 |
| 11 Sep 2024 |
SHENOUDA MAGED |
Chief Financial Officer |
11 Sep 2024 |
24,120 |
2.95 |
71,154 |
| 11 Sep 2024 |
SHENOUDA MAGED |
Chief Financial Officer |
10 Sep 2024 |
21,118 |
2.73 |
57,652 |
| 11 Sep 2024 |
SHENOUDA MAGED |
Chief Financial Officer |
09 Sep 2024 |
8,194 |
2.55 |
20,895 |
| 11 Sep 2024 |
KELLY PAUL EDWARD |
Director |
09 Sep 2024 |
25,000 |
2.59 |
64,750 |
| 31 Jan 2024 |
TRAVERSA SERGIO |
Chief Executive Officer |
31 Jan 2024 |
27,460 |
4.00 |
109,752 |
| 31 Jan 2024 |
TRAVERSA SERGIO |
Chief Executive Officer |
30 Jan 2024 |
40,999 |
3.90 |
159,949 |
| 31 Jan 2024 |
TRAVERSA SERGIO |
Chief Executive Officer |
29 Jan 2024 |
31,541 |
3.71 |
117,036 |
| 31 Jan 2024 |
SHENOUDA MAGED |
Chief Financial Officer |
31 Jan 2024 |
6,875 |
4.06 |
27,943 |
| 31 Jan 2024 |
SHENOUDA MAGED |
Chief Financial Officer |
30 Jan 2024 |
15,000 |
3.89 |
58,323 |
| 31 Jan 2024 |
SHENOUDA MAGED |
Chief Financial Officer |
29 Jan 2024 |
10,800 |
3.65 |
39,450 |
| 31 Jan 2024 |
ENCE CHUCK |
CA and CO |
31 Jan 2024 |
13,670 |
4.05 |
55,429 |
| 31 Jan 2024 |
ENCE CHUCK |
CA and CO |
30 Jan 2024 |
14,500 |
3.87 |
56,053 |
| 31 Jan 2024 |
ENCE CHUCK |
CA and CO |
29 Jan 2024 |
10,800 |
3.65 |
39,438 |
| 24 May 2023 |
O'GORMAN CEDRIC |
Chief Medical Officer |
23 May 2023 |
10,000 |
3.18 |
31,800 |
| 12 Dec 2022 |
TRAVERSA SERGIO |
Chief Executive Officer |
08 Dec 2022 |
55,250 |
2.10 |
115,804 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock